Legend Biotech (LEGN) is a publicly traded Healthcare sector company. As of May 21, 2026, LEGN trades at $28.33 with a market cap of $5.01B and a P/E ratio of 0.00. LEGN moved +4.36% today. Year to date, LEGN is +38.45%; over the trailing twelve months it is -6.48%. Its 52-week range spans $16.24 to $51.77. Analyst consensus is strong buy with an average price target of $55.90. Rallies surfaces LEGN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for LEGN, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $28.33 |
| Market Cap | $5.01B |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $51.77 |
| 52-Week Low | $16.24 |
| Volume | 564 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
11 analysts cover LEGN: 0 strong buy, 10 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $55.90.